HealthSpark Capital

www.healthcap.eu

VCMatch tracks HealthSpark Capital as an investor focused on Biotech, Medtech, and Digital Health companies, Pre-Seed and Seed rounds, and Europe, Global, and United States markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Biotech, Medtech, Digital Health

Geography

Europe, Global, and United States

Investment Thesis

HealthCap positions itself as a life‑science investor and company creator that seeks both patient impact and strong financial returns by backing breakthrough therapeutics for high‑unmet‑need diseases. The firm emphasizes precision medicine, active operational involvement (board seats, recruitment support, long‑term company development), and a responsible, ESG‑aware approach across the investment lifecycle to create sustainable value for patients, healthcare systems, society and investors.

Is HealthSpark Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

HealthSpark Capital is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Medtech, Digital Health, and Pharma, especially across Europe, Global, and United States.

Focus statement

HealthCap focuses on "diseases with a high unmet medical need and breakthrough therapies" and is "looking to back companies developing targeted therapies for rare diseases, cancers, and genetic diseases," with an explicit emphasis on precision medicine — "developing the right medicine for the right patient."

Value Add

Company‑creator model and active ownership: the team takes board seats and uses its networks to recruit experienced management and board members ("One or more team partners take board seats and the team’s extensive scientific and industrial networks are used for the recruitment of experienced professionals to portfolio companies").
Deep medical expertise: "HealthCap has medical knowledge in its DNA" and the team spans medicine, pharmacology, biochemistry, engineering and finance.
Demonstrated track record and industrial productivity: "backed and built more than 130 companies, taken more than 45 companies public" and contributed to "more than 30 market‑approved pharmaceutical products... and 50 approved innovative medical devices."
Precision medicine focus: explicitly prioritizes stratified/targeted approaches ("Precision medicine – developing the right medicine for the right patient – is key to our investment strategy").
Integrated ESG and responsible investment practices: signatory to the Principles for Responsible Investment and operates fund-level SFDR alignment ("HealthCap fund HealthCap IX is promoting environmental and social characteristics in accordance with article 8 in the Sustainable Finance Disclosure Regulation (SFDR)").
Collaborative, multi‑stakeholder approach: partners with investors, academia, patients and other societal players to create value ("We take pride in collaborating with different groups including investors, the academic community, portfolio companies and patients").